Generalized Anxiety Disorder (GAD). Generalized anxiety disorder
Conditions
Interventions
Intervention 1: Forty people in intervention group: Patients under treatment with SSRI at a specific dose (Sertraline oral tablets at the dose of 25 mg once daily and may be increased to 100 mg daily,
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnosis of Generalized Anxiety Disorder by a physician based on the Hamilton Anxiety Rating Scale The patient has filled in the consent form and consciously enters the study and cooperates Age group 18 to 65 years old
Exclusion criteria
Exclusion criteria: The patient is pregnant or breastfeeding The patient has a major co-morbid psychological disorder (including depressive disorder, bipolar disorder, psychosis, and drug use) The patient has taken any antioxidant medication or supplement in the past month Taking medicine that has interaction with ginger The patient has co-morbid disease (other than neurological diseases)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of anxiety based on the Hamilton Anxiety Rating Scale. Timepoint: Measurement of severity and extent of improvement of anxiety at the beginning of the study (before the intervention) and 14, 28, 56 and 84 days after the start of use. Method of measurement: Hamilton Anxiety Rating Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Ataei
Hamedan University of Medical Sciences
Outcome results
None listed